TRVI
Trevi Therapeutics Inc
Clinical-stage biopharmaceutical company
CUSIP: 89532M101HealthcareUS1 holder
Total Value
$46.93M
Total Shares
5.13M
Net Share Change
+3.59M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Viking Global Investors
$46.93M5.13M shares
ADD+3.59M(+232.4%)